Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongxia Wei

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|May 4, 2026
Increased CD95<sup>+</sup> or CD160<sup>+</sup> double-negative T-cell subsets are associated with incomplete immune reconstitution in ART-treated people living with HIVJingli Peng, Yanyan Li, Jiale Xi, et al.
Chinese Medical Journal|December 3, 2024
Effectiveness of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people with HIV with historical drug resistance mutationsZiwei Chang, Hongyan Zhu, Yiting Zhang, et al.
Frontiers in Microbiology|December 2, 2022
Metagenomic next-generation sequencing for identification of central nervous system pathogens in HIV-infected patientsYunqi Zhu, Wenxuan Zhao, Xihong Yang, et al.
Frontiers in Immunology|January 26, 2023
A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-naïve patients with advanced HIV infection in Nanjing, ChinaMingli Zhong, Mengqing Li, Mingxue Qi, et al.
BMC Public Health|November 8, 2018
A health communication intervention to integrate partner testing with antiretroviral therapy service among men who have sex with men in China: an observational cohort studyYuting Lian, Yan Zhao, Joyce Wang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 18, 2015
[Study on economic burden caused by antiretroviral treatment for people living with HIV/AIDS and influencing factors in Nanjing]Xiayan Zhang, Meng Li, Yibing Feng, et al.
Cytokine & Growth Factor Reviews|May 4, 2020
Cytokine storm intervention in the early stages of COVID-19 pneumoniaXinjuan Sun, Tianyuan Wang, Dayong Cai, et al.
China CDC Weekly|May 22, 2026
Time to Antiretroviral Therapy Initiation After HIV Diagnosis in the Integrase Strand Transfer Inhibitor Era - Nanjing City, Jiangsu Province, China, 2021-2024Chenyu Ma, Jinjin Yang, Anni Liu, et al.
Frontiers in Microbiology|February 17, 2025
The role of mycobacteremia screening in enhancing non-tuberculous mycobacteria detection in hospitalized persons with HIVMengjiao Miao, Hongyan Zhu, Ziyao Liu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 14, 2015
[Compliance of antiviral therapy and influencing factors in people living with HIV/AIDS in Nanjing]Hongxia Wei, Meng Li, Xiayan Zhang, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|May 4, 2026
Increased CD95<sup>+</sup> or CD160<sup>+</sup> double-negative T-cell subsets are associated with incomplete immune reconstitution in ART-treated people living with HIVJingli Peng, Yanyan Li, Jiale Xi, et al.
Chinese Medical Journal|December 3, 2024
Effectiveness of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people with HIV with historical drug resistance mutationsZiwei Chang, Hongyan Zhu, Yiting Zhang, et al.
Frontiers in Microbiology|December 2, 2022
Metagenomic next-generation sequencing for identification of central nervous system pathogens in HIV-infected patientsYunqi Zhu, Wenxuan Zhao, Xihong Yang, et al.
Frontiers in Immunology|January 26, 2023
A retrospective clinical study of dolutegravir- versus efavirenz-based regimen in treatment-naïve patients with advanced HIV infection in Nanjing, ChinaMingli Zhong, Mengqing Li, Mingxue Qi, et al.
BMC Public Health|November 8, 2018
A health communication intervention to integrate partner testing with antiretroviral therapy service among men who have sex with men in China: an observational cohort studyYuting Lian, Yan Zhao, Joyce Wang, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|June 18, 2015
[Study on economic burden caused by antiretroviral treatment for people living with HIV/AIDS and influencing factors in Nanjing]Xiayan Zhang, Meng Li, Yibing Feng, et al.
Cytokine & Growth Factor Reviews|May 4, 2020
Cytokine storm intervention in the early stages of COVID-19 pneumoniaXinjuan Sun, Tianyuan Wang, Dayong Cai, et al.
China CDC Weekly|May 22, 2026
Time to Antiretroviral Therapy Initiation After HIV Diagnosis in the Integrase Strand Transfer Inhibitor Era - Nanjing City, Jiangsu Province, China, 2021-2024Chenyu Ma, Jinjin Yang, Anni Liu, et al.
Frontiers in Microbiology|February 17, 2025
The role of mycobacteremia screening in enhancing non-tuberculous mycobacteria detection in hospitalized persons with HIVMengjiao Miao, Hongyan Zhu, Ziyao Liu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|November 14, 2015
[Compliance of antiviral therapy and influencing factors in people living with HIV/AIDS in Nanjing]Hongxia Wei, Meng Li, Xiayan Zhang, et al.
Pageof 11